Clinical Trial Update: Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating allogeneic adipose-derived mesenchymal stem cells for recurrent glioblastoma or recurrent astrocytoma in patients undergoing craniotomy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma Grade Iv
• Astrocytoma Idh-mutant
• Glioblastoma Idh-wildtype

Drugs mentioned

• Allogeneic adipose-derived mesenchymal stem cells (allogeneic adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Mayo Clinic | Conditions: Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4 | Phase 1 | Status: RECRUITING